Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Delayed Price · USD
1.84
-0.05 (-2.65%)
At close: May 25, 2022 4:00 PM
1.90
0.06 (3.26%)
After-hours:May 25, 2022 4:38 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Revenue | 208.38 | 12.62 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth (YoY) | 1551.57% | - | - | - | - | - | - |
| Gross Profit | 208.38 | 12.62 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 37.23 | 30.63 | 19.25 | 19.14 | 15.04 | 12.95 | 6.58 |
| Research & Development | 46.94 | 63.42 | 42.16 | 33.79 | 49.97 | 9.59 | 6.61 |
| Operating Expenses | 84.17 | 94.05 | 61.41 | 52.93 | 65.01 | 22.54 | 13.19 |
| Operating Income | 124.21 | -81.43 | -61.41 | -52.93 | -65.01 | -22.54 | -13.19 |
| Other Expense / Income | 0.05 | -0.4 | -0.95 | -0.95 | -0.2 | -0.12 | -0.03 |
| Pretax Income | 124.16 | -81.04 | -60.46 | -51.98 | -64.81 | -22.41 | -13.16 |
| Income Tax | 1.33 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 122.83 | -81.04 | -60.46 | -51.98 | -64.81 | -22.41 | -13.16 |
| Net Income Common | 122.83 | -81.04 | -60.46 | -51.98 | -64.81 | -22.41 | -13.16 |
| Shares Outstanding (Basic) | 67 | 58 | 39 | 25 | 19 | 10 | 10 |
| Shares Outstanding (Diluted) | 68 | 58 | 39 | 25 | 19 | 10 | 10 |
| Shares Change | 16.45% | 49.04% | 59.22% | 27.33% | 96.62% | 1.44% | - |
| EPS (Basic) | 1.78 | -1.39 | -1.54 | -2.11 | -3.35 | -2.28 | -1.36 |
| EPS (Diluted) | 1.76 | -1.39 | -1.54 | -2.11 | -3.35 | -2.28 | -1.36 |
| Free Cash Flow Per Share | 1.75 | -0.89 | -1.30 | -1.85 | -1.63 | -1.81 | -0.57 |
| Gross Margin | 100.00% | 100.00% | - | - | - | - | - |
| Operating Margin | 59.61% | -645.40% | - | - | - | - | - |
| Profit Margin | 58.95% | -642.26% | - | - | - | - | - |
| Free Cash Flow Margin | 56.83% | -409.85% | - | - | - | - | - |
| Effective Tax Rate | 1.07% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA | 124.4 | -80.73 | -60.21 | -51.84 | -64.73 | -22.36 | -13.15 |
| EBITDA Margin | 59.70% | -639.83% | - | - | - | - | - |
| EBIT | 124.16 | -81.04 | -60.46 | -51.98 | -64.81 | -22.41 | -13.16 |
| EBIT Margin | 59.58% | -642.26% | - | - | - | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).